The mechanistic contrast matters clinically: a satiety-hormone agonist and a central stimulant produce different side-effect profiles, different cardiovascular considerations, and different rules about how long a patient can stay on the drug
Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving
Where there appears to be some fat loss, the effect is quite limited
By fostering an environment for improved behavioral health through continuous assessments and bespoke strategies, virtual care programs can significantly impact long-term weight health for GLP-1 users, setting a new standard for sustainable health practices and delivering success at a population level.
Show Sources SOURCES: Photo Credit: iStock/Getty Images StatPearls [Internet] : "Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs)." Diabetes, Obesity, and Metabolism : "Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies." Society of Behavioral Medicine: "What are GLP-1 Medications